Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study
Fiche du document
- handle: 10670/1.4cu91q
- hal: hal-02152426
- doi: 10.1007/s12325-019-00957-y
- PUBMED: 31049873
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1007/s12325-019-00957-y
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/31049873
info:eu-repo/semantics/OpenAccess
Mots-clés
Disease knowledge Glucose control Patient information Pharmacist Type 2 diabetes -bio] -bio]/Pharmaceutical sciences -bio]/Human health and pathology/Endocrinology and metabolismSujets proches
TherapyCiter ce document
Yves Michiels et al., « Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study », Archive ouverte de Sciences Po (SPIRE), ID : 10.1007/s12325-019-00957-y
Métriques
Partage / Export
Résumé
INTRODUCTION:Low-quality communication between patients and care providers and limited patient knowledge of the disease and the therapy are important factors associated with poor glycemic control in patients with type 2 diabetes. We conducted a multicenter study to determine whether structured and tailored information delivered by pharmacists to type 2 diabetic patients could improve patient treatment adherence, hemoglobin A1c (HbA1c) levels and knowledge about diabetes.METHODS:One hundred seventy-four pharmacies were randomized to deliver an educational program on diet, drug treatment, disease and complications during three 30-min interviews over a 6-month period, or to provide no intervention, to type 2 diabetic patients treated with oral antidiabetic agents. Medication adherence was assessed by measuring the medication possession ratio and diabetes control by collecting HbA1c values. Levels of patient treatment self-management and disease knowledge were assessed using self-questionnaires.RESULTS:Three hundred seventy-seven patients were analyzed. The medication possession ratio, already very high at baseline in the intervention (94.8%) and control (92.3%) groups, did not vary significantly after 6 months with no difference between the two groups. Significant decreases in HbA1c were observed in both groups at 6 months (p